KOREA WHO

Yun Woong-sup is the Vice Chairman and CEO of Ildong Pharmaceutical.

He is focusing on new drug development with the goal of achieving annual sales of KRW 1 trillion (US$ 721.1 million) and a net profit of KRW 100 billion (US$ 72.1 million).

He was born on July 7, 1967, in Seoul as the eldest son of Yun Won-young, Chairman of Ildong Holdings.

He graduated from Youngdong High School in Seoul and Yonsei University with a degree in applied statistics, then earned a master's degree in accounting from Georgia State University in the United States.

He worked as a reporter at the Georgia bureau of The Korea Times before joining KPMG in the U.S. as an accountant.

He joined Ildong Pharmaceutical as an executive director, serving as the head of the PI team and director of the planning and coordination office before being appointed as Executive Vice President. In 2014, he became the co-CEO and President of Ildong Pharmaceutical.

As Ildong Pharmaceutical transitioned to a holding company structure, he took on the role of CEO, fully initiating third-generation management.

When profitability declined, he implemented bold restructuring measures, leading the company back to profitability within four years.

#YunWoongsup #IldongPharmaceutical #pharmaceuticalindustry #newdrugdevelopment #Koreanbusiness #biopharma #executivemanagement #corporatestructure #businessleadership #KPMG